OncoSec launches mid-stage study of TAVO + Keytruda in TNBC [Seeking Alpha]
OncoSec Medical Incorporated (ONCS)
Last oncosec medical incorporated earnings: 12/13 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oncosec.com/tag/investor-relations
Company Research
Source: Seeking Alpha
OncoSec Medical (NASDAQ: ONCS ) initiates an open-label Phase 2 clinical trial, KEYNOTE-890 , evaluating the combination of TAVO (intratumoral plasma-encoded IL-12, or tavokinogene telseplasmid, plus electroporation) and Merck's (NYSE: MRK ) KEYTRUDA (pembrolizumab) in patients with late-stage triple negative breast cancer (TNBC) who have received at least one prior line of treatment. The primary endpoint is objective response rate (ORR) at ~year 2. The estimated primary completion date is August 2019. This is the second trial assessing the combination. The first , in metastatic melanoma, is recruiting patients. Click to subscribe to real-time analytics on MRK Now read: Arvinas Holding Prepares Terms For $100 Million IPO » Subscribe for full text news in your inbox
Show less
Read more
Impact Snapshot
Event Time:
ONCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCS alerts
High impacting OncoSec Medical Incorporated news events
Weekly update
A roundup of the hottest topics